Qamre Alam: Identifying the Genetic Causes of Miscarriage Through QF-PCR Testing
Qamre Alam, Adjunct Assistant Professor at University of Bahrain, College of Science, Department of Biology, shared post on LinkedIn:
“QF-PCR testing coupled with Genetic Analyzer technology for Products of Conception (POC) samples at the Genomic Department, Expressmed Diagnostics and Research, Bahrain.
This advanced test plays a vital role in identifying the genetic causes of miscarriage or termination of pregnancy, helping couples and clinicians make informed decisions for future family planning.
Case of the Week:
Recently, we analyzed a POC sample from a patient with a history of six recurrent miscarriages at 2 weeks of pregnancy. Through QF-PCR, we identified triploidy (69 chromosomes) as the underlying genetic cause.
What is Triploidy?
Triploidy is a severe chromosomal abnormality where the fetus has three complete sets of chromosomes (69 instead of the normal 46). This condition is not compatible with life and is one of the common genetic causes of early miscarriage.
With this knowledge, the patient can now consider IVF with Preimplantation Genetic Testing for Aneuploidy (PGT-A), increasing the chances of achieving a successful pregnancy and having a healthy baby.
Genetic and Chromosomal Causes of Miscarriage:
- Nearly 50–60 percent of first-trimester miscarriages are due to chromosomal abnormalities.
- Aneuploidy (extra or missing chromosomes) is the most common cause (for example, trisomy, monosomy, triploidy).
- These errors usually occur during egg or sperm formation (meiosis) or early embryo division.
- Identifying the cause provides closure for families and guides the next steps in reproductive planning.
Why QF-PCR for POC Testing?
- Rapid and reliable detection of common chromosomal abnormalities.
- Provides critical insights into recurrent pregnancy loss.
- Supports tailored reproductive options, including IVF with PGT-A.
At Expressmed Diagnostics and Research, we are committed to providing state-of-the-art genetic testing that empowers patients and supports clinicians in delivering personalized care.”

-
Sep 12, 2026, 17:18Emad Sedeek: New Technologies in the IVF Laboratory
-
Sep 12, 2026, 17:16Rahul Singh Parmar: IVF Lab QC – Culture Medium vs. EmbryoGlue
-
Sep 12, 2026, 17:14The Countdown to the FIGO Montréal 2027 Call for Submissions Is On
-
Sep 12, 2026, 17:11Kevin Pho: For Anyone Who Prescribes Testosterone or Runs a Fertility Practice
-
Sep 12, 2026, 17:08Diane Horsfield: Building Individually Owned Fertility Insurance at Flora Fertility
-
Sep 12, 2026, 17:06Carmen Mair: 5 Things in Fertility that Can’t Be Improved
-
Sep 12, 2026, 17:04Aumatma Simmons: 2 Methods for Accurate Fertility Tracking
-
Sep 12, 2026, 17:02Sometimes, Getting Another Perspective Can Bring a Little More Clarity – Viera Fertility
-
Sep 12, 2026, 17:00Applications Are Open for Cloudnine’s 1-Year Fellowship in Reproductive Medicine for OB/GYNs
